Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall Street tumbles as hot inflation data feeds worries about Fed rate hikes
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Rigel Pharmaceuticals (RIGL) PT Raised to $49 at Citi
November 11, 2024 6:59 AM ESTCiti analyst Yigal Nochomovitz raised the price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $49.00 (from $40.00) while maintaining a Buy rating.
The analyst comments "Gavreto posted an unexpectedly strong quarter with $7.1M in sales (driven by demand not stocking) vs. our/consensus ests of... More



